Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 22128185)

1.

Stem cell gene SALL4 suppresses transcription through recruitment of DNA methyltransferases.

Yang J, Corsello TR, Ma Y.

J Biol Chem. 2012 Jan 13;287(3):1996-2005. doi: 10.1074/jbc.M111.308734. Epub 2011 Nov 29.

2.
3.

Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.

Lu J, Jeong HW, Kong N, Yang Y, Carroll J, Luo HR, Silberstein LE, Yupoma, Chai L.

PLoS One. 2009;4(5):e5577. doi: 10.1371/journal.pone.0005577. Epub 2009 May 18. Erratum in: PLoS One. 2009;4(7). doi: 10.1371/annotation/e0bd3a57-1ce4-4eaf-83de-034d39cac787. Jeong, Hawon [corrected to Jeong, Ha-Won].

4.

Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells.

Liu L, Souto J, Liao W, Jiang Y, Li Y, Nishinakamura R, Huang S, Rosengart T, Yang VW, Schuster M, Ma Y, Yang J.

J Biol Chem. 2013 Nov 29;288(48):34719-28. doi: 10.1074/jbc.M113.506568. Epub 2013 Oct 25.

7.
8.
9.

DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.

So AY, Jung JW, Lee S, Kim HS, Kang KS.

PLoS One. 2011 May 10;6(5):e19503. doi: 10.1371/journal.pone.0019503.

12.
13.

Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.

Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC, Ma Y.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10494-9. Epub 2007 Jun 8.

14.

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.

Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA.

Oncogene. 2001 Nov 22;20(53):7787-96.

15.

An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B.

Yang L, Mei Q, Zielinska-Kwiatkowska A, Matsui Y, Blackburn ML, Benedetti D, Krumm AA, Taborsky GJ Jr, Chansky HA.

Biochem J. 2003 Feb 1;369(Pt 3):651-7.

16.

Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.

Claus R, Fliegauf M, Stock M, Duque JA, Kolanczyk M, L├╝bbert M.

J Leukoc Biol. 2006 Dec;80(6):1462-72. Epub 2006 Sep 25.

18.

Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.

Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ.

Oncogene. 2003 Jun 19;22(25):3943-51.

PMID:
12813468
19.

The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.

Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.

J Biochem. 2005 Mar;137(3):431-40.

PMID:
15809347
20.

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.

Oncogene. 2003 Jul 17;22(29):4509-16.

PMID:
12881707
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk